Evelo Biosciences, Inc. (OTCPK: EVLO)
Health Care · Biotechnology · US
$0.00
— today · -80.0% 1Y
Evelo Biosciences, Inc. (OTCPK: EVLO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.90K and employs 66 people.
Over the last twelve months the share price has lost 80.0%, trading between 0.00 and 0.00.
Tweenvest scores Evelo Biosciences, Inc. across four factors: quality 21/100, value 35/100. Its strongest factor is value.
EVLO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.90K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -9.65
- Dividend yield
- —
- Beta (5Y)
- -28.58
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.98M
- Employees
- 66
- Next earnings
- —
About Evelo Biosciences, Inc.
Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases. Its pipeline includes EDP1815, a whole-microbe compound designed to address inflammatory ailments, currently undergoing Phase 2 clinical trials for conditions such as psoriasis and atopic dermatitis, and also being evaluated for the hyperinflammatory reaction associated with COVID-19. Additional developments include EDP1867, an inactivated oral biologic in Phase 1b for inflammatory diseases; EDP2939, an investigational oral biologic based on extracellular vesicles targeting inflammatory diseases; and EDP1908, a drug candidate focused on cancer. Established in 2014, Evelo Biosciences, Inc. operates from its headquarters in Cambridge, Massachusetts.
- ISIN
- US2997342025
- Founded
- 2014
- Listed since
- May 8, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $2.43K | $— | — |
| OncoVista Innovative Therapies, Inc.OTCPK: OVIT | $2.36K | $— | — |
| Lipella Pharmaceuticals Inc.OTCPK: LIPO | $2.31K | $0.00 | -98.47% |
| IMAC Holdings, Inc.OTCPK: BACK | $2.27K | $0.00 | +20.00% |
| RegeneRx Biopharmaceuticals, Inc.OTCPK: RGRX | $1.66K | $— | — |
| Evolutionary Genomics, Inc.OTCPK: FNAM | $1.33K | $— | — |
| GlobeStar Therapeutics CorporationOTCPK: GSTC | $1.24K | $— | — |
| Adhera Therapeutics, Inc.OTCPK: ATRX | $1.16K | $— | — |
Figures last refreshed Oct 4, 2026.